Literature DB >> 18445668

High molecular mass multimer complexes and vascular expression contribute to high adiponectin in the fetus.

H Pinar1, S Basu, K Hotmire, L Laffineuse, L Presley, M Carpenter, P M Catalano, S Hauguel-de Mouzon.   

Abstract

CONTEXT: High plasma adiponectin concentrations in human fetuses and neonates are unique features of early developmental stages. Yet, the origins of the high adiponectin concentrations in the perinatal period remain elusive.
OBJECTIVE: This study was undertaken to identify the sources and functional properties of adiponectin in utero. DESIGN AND METHODS: Tissue specimens were obtained at autopsy from 21- to 39-wk-old stillborn human fetuses. Adipose tissue and placenta were obtained at term elective cesarean section. Adiponectin complexes and expression were measured by immunodetection and real-time PCR.
RESULTS: Adiponectin mRNA transcripts were detected in fetal sc and omental adipose depots at lower concentrations than in maternal adipose tissue. Immunoreactive adiponectin was also observed in vascular endothelial cells of fetal organs, including skeletal muscle, kidney, and brain. The absence of adiponectin in all placental cell types and lack of correlation between maternal and umbilical adiponectin indicate that umbilical adiponectin reflects its exclusive production by fetal tissues. The most prominent forms of adiponectin in fetal plasma were high and low molecular mass (HMW and LMW) multimers of 340 and 160 kDa, respectively. The proportion of the HMW complexes was 5-fold (P < 0.001) higher in umbilical plasma than in adult. The high HMW and total adiponectin levels were associated with lower insulin concentration and lower homeostasis model of assessment of insulin resistance indices in umbilical plasma, reflecting higher insulin sensitivity of the fetus compared with adult.
CONCLUSIONS: The abundance of HMW adiponectin and its vascular expression are characteristics of human fetal adiponectin. Combined with high insulin sensitivity, fetal adiponectin may be a critical determinant of in utero growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445668      PMCID: PMC2453055          DOI: 10.1210/jc.2008-0009

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  A novel serum protein similar to C1q, produced exclusively in adipocytes.

Authors:  P E Scherer; S Williams; M Fogliano; G Baldini; H F Lodish
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

2.  Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult.

Authors:  H M Farrag; L M Nawrath; J E Healey; E J Dorcus; R E Rapoza; W Oh; R M Cowett
Journal:  Am J Physiol       Date:  1997-01

3.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

4.  Intrauterine growth and adipose tissue development.

Authors:  G Enzi; V Zanardo; F Caretta; E M Inelmen; F Rubaltelli
Journal:  Am J Clin Nutr       Date:  1981-09       Impact factor: 7.045

5.  Adiponectin as a biomarker of the metabolic syndrome.

Authors:  Miwa Ryo; Tadashi Nakamura; Shinji Kihara; Masahiro Kumada; Satomi Shibazaki; Mihoko Takahashi; Masaki Nagai; Yuji Matsuzawa; Tohru Funahashi
Journal:  Circ J       Date:  2004-11       Impact factor: 2.993

6.  Adiponectin expression in human fetal tissues during mid- and late gestation.

Authors:  S Corbetta; G Bulfamante; D Cortelazzi; V Barresi; I Cetin; G Mantovani; S Bondioni; P Beck-Peccoz; A Spada
Journal:  J Clin Endocrinol Metab       Date:  2004-12-28       Impact factor: 5.958

7.  Adiponectin is reduced in gestational diabetes mellitus in normal weight women.

Authors:  Trine Ranheim; Fred Haugen; Anne Cathrine Staff; Kristin Braekke; Nina K Harsem; Christian A Drevon
Journal:  Acta Obstet Gynecol Scand       Date:  2004-04       Impact factor: 3.636

8.  AdipoQ is a novel adipose-specific gene dysregulated in obesity.

Authors:  E Hu; P Liang; B M Spiegelman
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

9.  Hyperadiponectinemia in newborns: relationship with leptin levels and birth weight.

Authors:  Inês M C G Pardo; Bruno Geloneze; Marcos A Tambascia; Antonio A Barros-Filho
Journal:  Obes Res       Date:  2004-03

10.  Discrimination between obesity and insulin resistance in the relationship with adiponectin.

Authors:  Fahim Abbasi; James W Chu; Cindy Lamendola; Tracey McLaughlin; John Hayden; Gerald M Reaven; Peter D Reaven
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  17 in total

Review 1.  The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction.

Authors:  Konstantinos G Michalakis; James H Segars
Journal:  Fertil Steril       Date:  2010-06-19       Impact factor: 7.329

2.  Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth.

Authors:  Fredrick J Rosario; Michael A Schumacher; Jean Jiang; Yoshikatsu Kanai; Theresa L Powell; Thomas Jansson
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

3.  Patterns of adiponectin expression in term pregnancy: impact of obesity.

Authors:  Maricela Haghiac; Subhabrata Basu; Larraine Presley; David Serre; Patrick M Catalano; Sylvie Hauguel-de Mouzon
Journal:  J Clin Endocrinol Metab       Date:  2014-05-05       Impact factor: 5.958

Review 4.  Adiponectin action from head to toe.

Authors:  Karine Brochu-Gaudreau; Charlotte Rehfeldt; Richard Blouin; V Bordignon; Bruce D Murphy; Marie-France Palin
Journal:  Endocrine       Date:  2009-12-01       Impact factor: 3.633

Review 5.  Implications of Lipids in Neonatal Body Weight and Fat Mass in Gestational Diabetic Mothers and Non-Diabetic Controls.

Authors:  Emilio Herrera; Henar Ortega-Senovilla
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

6.  Full-length adiponectin attenuates insulin signaling and inhibits insulin-stimulated amino Acid transport in human primary trophoblast cells.

Authors:  Helen N Jones; Thomas Jansson; Theresa L Powell
Journal:  Diabetes       Date:  2010-02-11       Impact factor: 9.461

7.  In utero gender dimorphism of adiponectin reflects insulin sensitivity and adiposity of the fetus.

Authors:  Subhabrata Basu; Laura Laffineuse; Larraine Presley; Judi Minium; Patrick M Catalano; Sylvie Hauguel-de Mouzon
Journal:  Obesity (Silver Spring)       Date:  2009-02-05       Impact factor: 5.002

8.  Adiponectin enhances mouse fetal fat deposition.

Authors:  Liping Qiao; Hyung Sun Yoo; Alysha Madon; Brice Kinney; William W Hay; Jianhua Shao
Journal:  Diabetes       Date:  2012-08-07       Impact factor: 9.461

9.  Body composition and circulating high-molecular-weight adiponectin and IGF-I in infants born small for gestational age: breast- versus formula-feeding.

Authors:  Francis de Zegher; Giorgia Sebastiani; Marta Diaz; David Sánchez-Infantes; Abel Lopez-Bermejo; Lourdes Ibáñez
Journal:  Diabetes       Date:  2012-05-29       Impact factor: 9.337

10.  Adiponectin: are measurements clinically useful in pregnancy?

Authors:  Sylvie Hauguel-de Mouzon; Patrick Catalano
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.